Preferentially expressed antigen in melanoma (PRAME) is a cancer testis antigen (CTA) that
is selectively expressed in certain somatic tissues, predominantly in the testis, and is …

Introduction The curative basis of allogeneic hematopoietic stem cell transplantation (HSCT)
relies in part upon the graft versus leukemia (GvL) effect, whereby donor immune cells …

Prussian blue nanoparticle‐based photothermal therapy (PBNP‐PTT) is an effective tumor
treatment capable of eliciting an antitumor immune response. Motivated by the ability of …

Pediatric acute lymphoblastic leukemia (ALL) is the most common subtype of childhood
leukemia, which is characterized by the abnormal proliferation and accumulation of …

Purpose: Uveal melanoma (UM) is a rare disease with a high mortality, and new therapeutic
options are being investigated. Preferentially Expressed Antigen in Melanoma (PRAME) is a …

For patients with high-risk or relapsed/refractory acute myeloid leukemia (AML), allogeneic
stem cell transplantation (allo-HSCT) and the graft-versus-leukemia effect mediated by …

T-cell receptor (TCR) therapies are a promising modality for the treatment of cancers, with
significant efforts being directed towards acute myeloid leukaemia (AML), a particularly …

Post-transplant cyclophosphamide (PTCy) allows safe and effective partially matched donor
allogeneic blood or marrow transplantation (alloBMT), so that almost everyone in need of …

Background Adoptive T cell therapy (ATCT) has been successful in treating hematological
malignancies and is currently under investigation for solid-tumor therapy. In contrast to …

Posttransplant lymphoproliferative disease (PTLD) in pediatric solid organ transplant (SOT)
recipients is characterized by uncontrolled proliferation of Epstein-Barr virus–infected …